Geschäft · 23.12.19971 Min. Lesezeit
Implantation and Injectable Dosage Form New Animal Drugs; Imidocarb Dipropionate
Lokale automatische Übersetzung · Originalsprache der Quelle
Zusammenfassung
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Schering-Plough Animal Health Corp. The NADA provides for subcutaneous or intramuscular use of imidocarb dipropionate solution for dogs for treatment of babesiosis.